Följ
Shrey Kanvinde
Shrey Kanvinde
Moderna Inc.
Verifierad e-postadress på modernatx.com
Titel
Citeras av
Citeras av
År
The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal
R Roggers, S Kanvinde, S Boonsith, D Oupický
Aaps Pharmscitech 15, 1163-1171, 2014
702014
Surface PEGylation of Mesoporous Silica Nanorods (MSNR): Effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells.
SB D. Oupicky. A. Wani, G. H. Layan Savithra, A. Abyad, S. Kanvinde, J. Li
Scientific Reports, 2017
452017
Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease
S Kanvinde, YS Chhonker, R Ahmad, F Yu, R Sleightholm, W Tang, ...
Acta biomaterialia 82, 158-170, 2018
282018
Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer
Y Zhu, J Li, S Kanvinde, Z Lin, S Hazeldine, RK Singh, D Oupický
Molecular pharmaceutics 12 (2), 332-341, 2015
272015
Non-viral vectors for delivery of nucleic acid therapies for cancer
S Kanvinde, T Kulkarni, S Deodhar, D Bhattacharya, A Dasgupta
BioTech 11 (1), 6, 2022
212022
Simultaneous quantitation of lipid biomarkers for inflammatory bowel disease using LC–MS/MS
YS Chhonker, S Kanvinde, R Ahmad, AB Singh, D Oupický, DJ Murry
Metabolites 11 (2), 106, 2021
172021
Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases
CM Jogdeo, S Panja, S Kanvinde, E Kapoor, K Siddhanta, D Oupický
Advanced Healthcare Materials 12 (7), 2202400, 2023
82023
The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal
F Tang, L Li, D Chen, N Products, A For, USE Or, R Roggers, S Kanvinde, ...
Nano Today 46 (3), 1278-1288, 2013
62013
DEGRADABLE AND NON-DEGRADABLE POLYMERIC CHLOROQUINE: ALTERING CHLOROQUINE'S PHARMACOKINETICS FOR TRANSLATIONAL IMPROVEMENTS IN INFLAMMATORY BOWEL DISEASE AND CANCER.
R Sleightholm, S Kanvinde, Y Chhonker, D Oupicky, DJ Murry
Clinical Pharmacology & Therapeutics 103, S50-S51, 2018
22018
Development of Novel Therapies for the Treatment of Inflammatory Bowel Disease
S Kanvinde
22018
Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis
S Kanvinde, S Deodhar, TA Kulkarni, CM Jogdeo
BioTech 12 (2), 34, 2023
2023
Figures have been reproduced with permission from respective sources.
CM Jogdeo, S Panja, S Kanvinde, E Kapoor, K Siddhanta, D Oupický, ...
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–12